Morphology, p16, HPV, and outcomes in squamous cell carcinoma of the penis: a multi-institutional study.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
02 2020
Historique:
received: 19 08 2019
accepted: 12 09 2019
pubmed: 8 11 2019
medline: 15 7 2020
entrez: 8 11 2019
Statut: ppublish

Résumé

Our objective was to evaluate the pathologic features and clinical outcomes in cases of invasive penile squamous cell carcinoma (SCC) and the association with p16 immunohistochemistry (IHC) and human papilloma virus (HPV) in situ hybridization (ISH). A retrospective multi-institutional database search was conducted for invasive SCC of the penis diagnosed between 2007 and 2018 that had undergone surgical resection. Pathologic features, p16 IHC, and HPV ISH were investigated with clinical outcomes. A total of 102 patients were included in the study. The average age was 63 ± 13.3 years. Based on histology, 46% of tumors displayed an HPV-related subtype, whereas p16 was positive in 52% of all cases. Tumor histology correlated well with p16 positivity (P < .001), and p16 IHC accurately predicted the presence of HPV in 25/26 (96%) cases. On multivariate analysis, perineural invasion was associated with local disease recurrence (P = .02), whereas lymphovascular invasion was associated with progression to metastatic disease (P = .002) and increased overall mortality (P = .02). Urethral involvement was also associated with increased overall mortality (P = .02). In addition, HPV-related tumors based on histologic features correlated with lower rates of metastatic disease (P = .007). HPV is a common cause of penile SCC and can be diagnosed by tumor histology and confirmed by overexpression of p16 on IHC. The presence of lymphovascular invasion, perineural invasion, and urethral involvement are poor prognostic indicators, whereas HPV-related tumors based on histology may have lower risk for metastatic disease.

Identifiants

pubmed: 31698006
pii: S0046-8177(19)30192-3
doi: 10.1016/j.humpath.2019.09.013
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
CDKN2A protein, human 0
Cyclin-Dependent Kinase Inhibitor p16 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-86

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Marie-Lisa Eich (ML)

Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294 USA.

Maria Del Carmen Rodriguez Pena (M)

Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294 USA.

Lauren Schwartz (L)

Department of Pathology, University of Pennsylvania, Philadelphia, PA, 19104 USA.

Carlos Prieto Granada (CP)

Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294 USA.

Soroush Rais-Bahrami (S)

Department of Urology, University of Alabama at Birmingham, Birmingham, AL, 35294 USA; Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, 35294 USA; O'Neal Comprehensive Cancer Center at UAB, University of Alabama at Birmingham, Birmingham, AL, 35294 USA.

Giovanna Giannico (G)

Department of Pathology, Vanderbilt University, Nashville, TN, 37212 USA.

Belkiss Murati Amador (BM)

Department of Pathology, Johns Hopkins University, Baltimore, MD, 21287 USA.

Andres Matoso (A)

Department of Pathology, Johns Hopkins University, Baltimore, MD, 21287 USA.

Jennifer B Gordetsky (JB)

Department of Pathology, Vanderbilt University, Nashville, TN, 37212 USA; Department of Urology, Vanderbilt University, Nashville, TN, 37212 USA. Electronic address: jennifer.b.gordetsky@vumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH